Squalene Market by Source Type (Animal Source, Vegetable Source, and Biosynthetic Source), End-Use Industry (Cosmetics, Food, Pharmaceuticals, Others): Global Market Size Estimates and Forecast (2022–2030)

The market crossed US$ 143.0 million in 2022 and is expected to hit US$ 230.6 million by 2030, recording a CAGR of 6.2% during the forecast period.

Squalene has been significantly growing with the high adoption of food segment.

Squalene is used in different food products to enhance its nutritional value. These are used to produce some dietary supplements like capsules and tablets. The demand for squalene in the food industry depends on growth of the dietary supplements in the nutraceuticals industry. The food segment is expected to pace up with the rising population and growth. Further, other segment such as biosynthetic segment is also expected to gain traction during the forecasted year.

Within the report, the market is segmented into source type, end-user industry and geography. By source type, the market is further segmented into animal source, vegetable source, and biosynthetic source. On the basis of end-user industry, the market is bifurcated into cosmetics, food, pharmaceuticals, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Increasing demand from the pharmaceutical industry is elevating the growth of the squalene market.

Squalene is extensively used in numerous vaccines and drug delivery emulsions. It is also used in ointment bases as a spreading agent. The improved lifestyle of the consumers and the growing pharmaceutical industry have also added value to the overall market of squalene. Squalene is also used in various health supplements which includes alkylglycerols, these are consumed to prevent viruses and infections, thereby growing the squalene market. Severe circumstances such as asthma, psoriasis, and arthritis may also be improved by it.

Rising adoption in hygiene and personal grooming activities is one of the major factors accelerating the market growth.

Increase in demand in the hygiene and personal grooming activities has driven the demand for various products where squalene is widely used, such as in producing creams and lotions to increase their spread absorption properties. This acts as one of the key drivers in the squalene market. In addition, squalene supplementation has shown positive effects in humans, owing to its potential to reduce human cholesterol levels, normalize plasma sterol levels, and enhance the overall immunity of humans. This factor has led to rise in popularity of squalene in nutraceuticals products; thus, driving the growth of the squalene market.

Recent strategic developments in squalene market

The squalene market has undergone several significant developments, and a few of these have been mentioned below:

• In August 2021, Amyris, Inc. company launched Rose Inc., a cosmetics brand. The products’ non-comedogenic formulas are developed with proprietary bioengineered and sustainably-sourced ingredients, which include squalene and hemisqualane.
• In September 2021, SOPHIM launched a natural emollient named Sugar Squalene, which is produced from sugarcane via sucrose fermentation. A process of fermentation, distillation, dimerization, and hydrogenation transforms this sesquiterpene, into sugar squalene.
• In August 2021, Amyris, Inc. launched Terasana Clinical, a clean skincare brand. The products of this brand have a patented formulation that combines two of Amyris, Inc.'s sustainably sourced ingredients, squalene and cannabigerol (CBG).

The squalene market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Amyris Inc., SOPHIM, Merck KGaA, Nucelis, and Vestan S.A.  are among the prominent players operating in the market.

Target audience for the report:

• Raw material providers
• Pharmaceuticals providers
• Food manufacturers
• Cosmetics manufacturers
• Food related associations, organizations, forums, and alliances
• Government bodies, such as regulating authorities and policy makers
• Venture capitalists, private equity firms, and start-up companies
• Personal care suppliers
• Pharmaceutical distributors and sales firms
• End users of cosmetics products
• Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

• Source Type:
  • Animal Source
  • Vegetable Source
  • Biosynthetic Source

• End-Use Industry
  • Food
  • Cosmetics
  • Pharmaceuticals
  • Others
• Region
  • North America
  • Europe
  • Asia Pacific (APAC)
  • South & Central America
  • Middle East & Africa
• Companies profiled
  • Amyris Inc.
  • SOPHIM
  • Merck KGaA
  • Nucelis
  • Vestan S.A.

• Amyris Inc.
• SOPHIM
• Merck KGaA
• Nucelis
• Vestan S.A.